VRCA CIK: 1660334

Verrica Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−27.6
FY22:
−18.7
FY23:
−38.6
FY24:
−60.9
FY25:
−17.6
Change from FY21 to FY25
millions USD
FY21:
−1.00
FY22:
54.0
FY23:
−0.36
FY24:
−0.02
FY25:
0
Change from FY21 to FY25
millions USD
FY21:
33.6
FY22:
−16.9
FY23:
74.2
FY24:
37.7
FY25:
1.45
millions USD
FY21:
5.07
FY22:
18.5
FY23:
35.3
FY24:
−23.2
FY25:
−16.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−28.5
FY22:
−19.0
FY23:
−38.9
FY24:
−61.0
FY25:
−17.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data